We were recently featured by The Times “The best Botox doctors in the UK”
Haq, who has clinics in London and Northern Ireland, offers Letybo (from £300), otherwise known as letibotulinum toxin type A. This is a newly registered toxin in Europe and the first brand to be specifically tested in clinical trials on older patients (up to 75 years) as well as in a large male cohort. In the three studies, 1,200 patients were treated with Letybo repeatedly every 19 weeks for up to two years, in 27 centres in the US and Europe. “As we live longer, it’s very important that we are able to provide treatments that have been tested in the older patient population and show clear efficacy and safety. Older patients have weaker, thinner muscles, so one has to adjust the dose of toxin to account for this. Similarly with male patients a higher dose may be needed as the male face has more muscle bulk. With Letybo the clinicians have found the same dose works well on people of all ages and sexes, and this universal dosing will make it easier for practitioners to provide consistently good results with greater certainty.”
You can read the article below:
https://www.thetimes.co.uk/article/1d1f1ac7-ce6f-43a5-b440-d389b3dc3120